Goldman Sachs’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.3M Buy
896,387
+72,232
+9% +$2.28M ﹤0.01% 1528
2025
Q1
$27M Sell
824,155
-109,797
-12% -$3.6M ﹤0.01% 1477
2024
Q4
$33.8M Buy
933,952
+34,315
+4% +$1.24M 0.01% 1356
2024
Q3
$28.1M Buy
899,637
+309,304
+52% +$9.64M ﹤0.01% 1477
2024
Q2
$15.8M Buy
590,333
+275,439
+87% +$7.37M ﹤0.01% 1742
2024
Q1
$10.7M Buy
314,894
+75,763
+32% +$2.58M ﹤0.01% 1993
2023
Q4
$6.92M Buy
239,131
+81,821
+52% +$2.37M ﹤0.01% 2355
2023
Q3
$4.34M Sell
157,310
-33,863
-18% -$934K ﹤0.01% 2578
2023
Q2
$5.75M Sell
191,173
-92,608
-33% -$2.78M ﹤0.01% 2469
2023
Q1
$10.3M Sell
283,781
-35,078
-11% -$1.27M ﹤0.01% 1991
2022
Q4
$11.4M Buy
318,859
+97,127
+44% +$3.46M ﹤0.01% 2032
2022
Q3
$7.51M Sell
221,732
-85,751
-28% -$2.9M ﹤0.01% 2346
2022
Q2
$8.89M Sell
307,483
-242,598
-44% -$7.02M ﹤0.01% 2227
2022
Q1
$17.8M Buy
550,081
+285,737
+108% +$9.24M ﹤0.01% 1793
2021
Q4
$7.71M Buy
264,344
+2,734
+1% +$79.7K ﹤0.01% 2469
2021
Q3
$6.98M Buy
261,610
+10,254
+4% +$273K ﹤0.01% 2546
2021
Q2
$7.74M Buy
251,356
+58,243
+30% +$1.79M ﹤0.01% 2451
2021
Q1
$5.06M Sell
193,113
-153,127
-44% -$4.01M ﹤0.01% 2659
2020
Q4
$8.71M Buy
346,240
+99,045
+40% +$2.49M ﹤0.01% 2140
2020
Q3
$5.15M Buy
247,195
+8,230
+3% +$171K ﹤0.01% 2360
2020
Q2
$5.68M Sell
238,965
-275,885
-54% -$6.55M ﹤0.01% 2266
2020
Q1
$9.26M Sell
514,850
-184,163
-26% -$3.31M ﹤0.01% 1841
2019
Q4
$16.6M Buy
699,013
+378,809
+118% +$8.99M ﹤0.01% 1737
2019
Q3
$8.8M Buy
320,204
+150,673
+89% +$4.14M ﹤0.01% 2001
2019
Q2
$5.61M Sell
169,531
-120,121
-41% -$3.97M ﹤0.01% 2243
2019
Q1
$10.2M Buy
289,652
+65,125
+29% +$2.28M ﹤0.01% 2004
2018
Q4
$7.46M Sell
224,527
-92,221
-29% -$3.06M ﹤0.01% 2077
2018
Q3
$15.9M Sell
316,748
-129,954
-29% -$6.54M ﹤0.01% 1778
2018
Q2
$26.7M Sell
446,702
-19,895
-4% -$1.19M 0.01% 1459
2018
Q1
$21.4M Buy
466,597
+198,450
+74% +$9.09M 0.01% 1542
2017
Q4
$10.7M Sell
268,147
-33,176
-11% -$1.32M ﹤0.01% 1874
2017
Q3
$12.1M Buy
301,323
+96,484
+47% +$3.86M ﹤0.01% 1879
2017
Q2
$8.83M Buy
204,839
+26,357
+15% +$1.14M ﹤0.01% 1990
2017
Q1
$5.59M Sell
178,482
-40,180
-18% -$1.26M ﹤0.01% 2137
2016
Q4
$5.52M Buy
218,662
+10,326
+5% +$261K ﹤0.01% 2124
2016
Q3
$5.15M Buy
208,336
+169,922
+442% +$4.2M ﹤0.01% 2229
2016
Q2
$782K Sell
38,414
-15,202
-28% -$309K ﹤0.01% 3079
2016
Q1
$818K Buy
53,616
+19,840
+59% +$303K ﹤0.01% 2964
2015
Q4
$454K Buy
+33,776
New +$454K ﹤0.01% 3304
2015
Q3
Sell
-104,799
Closed -$1.78M 4698
2015
Q2
$1.78M Buy
104,799
+87,752
+515% +$1.49M ﹤0.01% 2633
2015
Q1
$206K Sell
17,047
-18,945
-53% -$229K ﹤0.01% 3879
2014
Q4
$299K Buy
35,992
+20,341
+130% +$169K ﹤0.01% 3697
2014
Q3
$136K Buy
15,651
+2,667
+21% +$23.2K ﹤0.01% 4127
2014
Q2
$142K Sell
12,984
-16,296
-56% -$178K ﹤0.01% 4108
2014
Q1
$262K Sell
29,280
-78,461
-73% -$702K ﹤0.01% 3754
2013
Q4
$812K Buy
+107,741
New +$812K ﹤0.01% 3177